the significance of tumor fraction in the context of patient selection for oncology trials
Published 1 year ago • 67 plays • Length 0:45Download video MP4
Download video MP3
Similar videos
-
2:24
incorporating a tumor agnostic approach in rare cancer clinical trials
-
4:44
phases of cancer clinical trials – an introduction, with neal meropol, md
-
22:01
clinical trials: the why and how
-
26:01
clinical trials for brain tumors
-
1:36:15
conversations on cancer: clinical trial site selection: fact vs fiction
-
39:10
the changing nature of phase i trials
-
44:38
clinical trials 101
-
1:06
the difference between hodgkin's and non-hodgkin's lymphoma cancers explained in 60 seconds
-
3:36
clinical trials development for people with rare cns cancers
-
1:49
dr. howard hochster discusses the importance of clinical trials in oncology
-
0:08
the nrg-gy022 study for patients with #cancer receiving carboplatin
-
5:47
cancer clinical trials in your community - nci community oncology research program (ncorp)
-
52:04
q&a roundtable: clinical trials for advancing brain tumor treatment
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
32:15
clinical trials for brain tumor patients | dana-farber cancer institute
-
50:08
clinical trials 101
-
0:54
role of patient advocacy in clinical trial design
-
17:25
promising clinical trials for glioblastoma - nicholas butowski, m.d.
-
19:42
innovating clinical trials: real-world clinical trial design and execution in oncology